Ruiwen Zhang Center for Drug Discovery University of Houston 3455 Cullen Blvd. Houston, TX 77204 USA
R. Agarwal University of Colorado Denver Aurora, CA USA
N. Neamati University of Michigan Ann Arbor, MI USA
P. Workman Cancer Research UK Centre for Cancer Therapeutics The Institute for Cancer Research Surrey England, UK
B.A. Teicher National Cancer Institute Bethesda, MD USA
Section: Molecular Oncology and Genomics
S.K. Srivastava University of South Alabama United States
Editorial Board Members
J.L.-S. Au Ohio State University Columbus, OH USA
J.J. Barchi, Jr National Cancer Institute Frederick, MD USA
D. Barreca Università di Messina Messina Italy Biography
Biography of D. Barreca
Davide Barreca is an Assistant Professor of biochemistry at the University of Messina. He is
specialized in enzyme modulation by natural compounds, inhibition of protein aggregation and
activation of signal apoptotic cascade. Most of his research projects concentrate on separation and
identification of unknown flavonoids, structural-activity elucidation, and biochemical analysis of
their health promoting or cytotoxicity properties on cells culture. He is author of over 90 papers in
peer-reviewed journals, 30 chapters in books, and 70 conference proceedings and reviewer of over
40 international scientific journals.
M. Breccia University of Rome “Sapienza” Rome Italy Biography
Biography of M. Breccia
Dr. Massimo Breccia is assistant physician at Sapienza University of Rome, Azienda Policlinico Umberto I. His scientific interests and publications as author or co-author (more than 300 papers in peer reviewed journals) are mainly focused on biological and clinical aspects of acute and chronic myeloid leukemias and myelodysplastic syndromes. He is a peer-reviewer for several journals such as Blood, Haematologica, Leukemia Research, British Journal of Haematology, etc and member of editorial board of 5 journal (Leukemia Research, Leukemia Research and Treatment, Hematology Reviews, etc).
He is a member of SIE, SIES, EHA and participates as study coordinator in several clinical trials for CML, AML and MDS. He is secretary of GIMEMA QoL Working Party.
M. Caraglia Second University of Naples Naples Italy
M.P. Carty National University of Ireland Galway City Ireland
P.J. Casey Duke-NUS Medical School Singapore Singapore Singapore
L.W.T. Cheung The University of Hong Kong Pokfulam Hong Kong Biography
Biography of L.W.T. Cheung
Dr. Cheung is an assistant professor in the School of Biomedical Sciences, University of Hong Kong. The focus of her research is functional characterization of genomic abnormalities in cancers (with a goal of ultimately devising the optimal therapeutic strategies for cancer patients). Her research revolutionizes the concept underlying precision cancer therapy (where mutations of the same cancer gene may have different functional impact and confer sensitivity to different drugs). She has published in Cancer Cell, Cancer Discovery, Cancer Research, Nature Communications, Genome Research, etc.
W. Cho Queen Elizabeth Hospital Hong Kong Hong Kong Biography
Biography of W. Cho
Dr William Cho main research interests have been focusing on cancer studies to discover biomarkers for cancer diagnosis, treatment prediction and prognostication. He has published over 230 peer-reviewed papers (Lancet Oncology, Clinical Cancer Research, Clinical Chemistry, Annuals of Oncology, etc) covering cancer biomarkers, proteomics, microRNAs, Chinese medicine and plenty of books including "MicroRNAs in cancer translational research", "An omics perspective on cancer research", "Supportive cancer care with Chinese medicine", etc. These papers have received >7,000 citations. Dr Cho is also a grant reviewer of the Hope Funds for Cancer Research (USA), Cancer Research (UK), National Medical Research Council (Singapore), etc.
S. De Flora University of Genoa Genoa Italy Biography
Biography of S. De Flora
MD in 1966. Assistant Professor in 1966, Full Professor in 1975, and Professor Emeritus in 2012 at the University of Genoa (Italy). Director of the Institute of Hygiene and Preventive Medicine (1986-1998) and Department of Health Sciences (1999-2005, 2010-2012). Author of 465 full length papers, 310 of which available in PubMed, cited more than 14,000 times. He collaborated with 150 laboratories all over the world. Member of the editorial board of 16 international journals. Principal investigator in a number of research projects, 10 of which awarded by the US NIH/NCI. He received several awards, among which the honor from MSU (2002), the Sobels Award (2005), and dedication of ICMAA (Brazil, 2010).
W.A. Denny The University of Auckland Auckland New Zealand
L. Ferguson University of Auckland Auckland New Zealand Biography
Biography of L. Ferguson
Prof Ferguson obtained a D. Phil. (Oxon,) from the University of Oxford. On her return to New Zealand, she developed a linkage with some anticancer drug developer, who were developing the Auckland Cancer Society Research Centre, based the The University of Auckland, New Zealand. Lynnette had become interested in applying her genetics traning to an understanding of adverse genetic effects of novel drugs. She joined the Cancer Research Centre to set up the Centre for Mutagen Testing, which still functions to test anticancer drugs, novel pharmaceutical products and occupational situations as caner hazards in New Zealand. He rstudies on causes of cancer have led to a sugnificant amount of work on the New Zealand diet, and she maintains a dual interest in drugs and nutrients in the treatment and cause of cancer.
T. W. Grunt Medical University Vienna (MUV) Vienna Austria Biography
Biography of T. W. Grunt
Dr. Grunt obtained a doctorate (Ph.D.) in Cell Biology from the University of Salzburg, Austria. Dr. Grunt also holds an Master of Science in Experimental Biology from the University of Salzburg.
Currently Dr. Grunt is also an Associate Professor in the Medical University of Vienna, Austria. He has published more than 80 scientific publications and is a named inventor of several U.S patents.
Dr. Grunt received several awards from the International Society of Differentiation (ISD), the Austrian Association of Clinical Oncology and from the Austrian Society of Hematology and Oncology. He is member of the American Association of Cancer Research (AACR), the European Association of Cancer Research (EACR), the International Society of Differentiation (ISD), the International Society of Cancer Metabolism (ISCaM), and the Union for International Cancer Control (UICC).
T.-C. He The University of Chicago Medical Center Chicago, IL USA
C. Huang New York University School of Medicine NY USA Biography
Biography of C. Huang
Chaunshu Huang is a Professor of Department of Environmental Medicine and Biochemistry and Molecular Pharmacology and Urology, and Deputy Director of Nelson Institute of Environmental medicine, New York University School of Medicine. Dr. Huang published more than 280 research papers with total citation over 11,200. Chuanshu’s major research addresses fundamental questions concerning the responses of mammalian cells to environmental carcinogens at the levels of protein kinases, transcription factors and their target genes, as well as protein modification both in vitro and in vivo. His research also includes elucidation of tumor invasion and metastasis, as well as screening and identifying novel anti-cancer drugs and the molecular mechanisms underlying their anti-cancer effect.
H. Kasuya Nagoya University School of Medicine Nagoya Aichi Japan Biography
Biography of H. Kasuya
Dr. Hideki Kasuya obtained a MD from Aichi Medical University, and a PhD in Medicine from Nagoya University Graduate School of Medicine. He is holing tile of FACS (Faculty of American College of Surgery). He spent a time in Mass General Hospital (Dept. of Surgery, Boston) as research fellow. Currently Dr. Hideki Kasuya is a Professor in Cancer Immune therapy, International Center for Medical Technology in USA, and Chairman of Cancer Immune Therapy in Nagoya University Graduate School of Medicine in Japan. Dr. Hideki Kasuya is currently the Editorial Advisory Board member (Current Cancer Drug Targets), published by Bentham Science Publishers.
J. Kuroda Kyoto Prefectural University of Medicine Japan Biography
Biography of J. Kuroda
Junya Kuroda, holder of M.D. and Ph.D. degrees, is an associate professor at the Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine in Kyoto, Japan, and has published more than 120 articles.
Junya Kuroda’s research interests focused on the identification of the disease–specific dysregulation of epigenetics, genetics, cytogenetics, and cell signaling, to develop novel therapeutic strategies and biomarkers for cancers, especially hematologic malignancies, such as leukemias, lymphomas, or myeloma, while also covers clinical researches in hematological oncology.
J. C. Lacal Instituto de Investigación Sanitaria IdiPAZ Madrid Spain
R. Lakshmanaswamy Texas Tech University Health Sciences Center at El Paso Texas, TX USA
J.-Y. Liu Indiana University-Purdue University at Indianapolis Indianapolis, IN USA
P. Marchetti INSERM U1172-S France
David Mu Eastern Virginia Medical School Norfolk, VA USA Biography
Biography of David Mu
Dr. Mu obtained his PhD degree in Chemistry from the University of California at Berkeley with Dr. Judith P. Klinman. Dr. Mu’s postdoctoral research on the topic of human nucleotide excision repair mechanism with Dr. Aziz Sancar at the University of North Carolina at Chapel Hill was cited by the 2015 Nobel Prize in Chemistry awarded to Dr. Aziz Sancar. At present, Dr. Mu is a Professor in the Eastern Virginia Medical School. He is currently on the Editorial Board of Scientific Reports (Nature Publishing Group) and Journal of Cytology and Molecular Biology (Avens Publishing).
D. Mukhopadhyay Mayo Clinic Cancer Center, Mayo Clinic Rochester, MN USA Biography
Biography of D. Mukhopadhyay
Debabrata (Dev) Mukhopadhyay, Ph.D.: Professor of Biochemistry
and Molecular Biology, Mayo Clinic College of Medicine, Jacksonville,
Florida, has a joint appointment with the Department of Physiology
and Biomedical Engineering. Before moving to Mayo Clinic as
Professor 14 years ago, he was research fellow and later independent
investigator followed by as an Associate Professor at Harvard Medical
School, Boston. He has been carried out angiogenesis and tumor
microenvironment related research and also leading translational
nanomedicine program including new drug delivery systems. He has
been serving as reviewer for several study sections in NIH and agencies. Recently, he has
been appointed as the Florida Department of Health Cancer Research Chair. He has
published more than 190 peer-reviewed papers in different journals including Nature, Nature
Medicine, Caner Cell, Cancer Research, Nano Letters. He has several patents and has been
involved to develop different start up companies in the area of therapy and diagnosis of the
V.C.O. Njar University of Maryland School of Medicine Baltimore, MD USA
F. Patrone University of Genova Genova Italy Biography
Biography of F. Patrone
Dr. Franco Patrone MD obtained specialization degrees in General Medicine, Hematology, and Oncology from the University of Genova, Italy.
Currently Dr. Patrone is an adjunct professor of Internal Medicine in the Departtment. of Internal Medicine, University of Genova. He has published more than 170 scientific publications reported on PubMed.
Dr. Patrone has been, director of the first Medical Clinic and of the Department of Internal Medicine, University of Genoa, as well as of the Internal Medicine and Oncology Clinic and of the Department of Hematology and Oncology, San Martino University Hospital, Genoa, Italy.
Y. Pommier National Cancer Institute Bethesda, MD USA Biography
Biography of Y. Pommier
Yves Pommier is the Chief of the Developmental Therapeutics Branch, NCI. He obtained his M.D. and Ph.D. from the University of Paris, and has studied DNA topoisomerases and the pharmacology of their inhibitors for the past 30 years. Three of his topoisomerase I inhibitors are in clinical trials. Dr. Pommier also discovered the first HIV-1 integrase inhibitors and the mechanism of action of poly(ADPribose) polymerase inhibitors by trapping PARP-DNA complexes. He pioneered the concept of drugs acting as interfacial inhibitors.
E. Prosperi CNR, Istituto di Genetica Molecolare Pavia Italy Biography
Biography of E. Prosperi
Dr. Prosperi graduated in Biological Sciences at the University of Pavia (Italy) and performed PhD studies in Physiological Sciences at the University of Milano, and in the Histochemistry Dept. of Leiden University” (Nederland). Dr. Prosperi is a Senior Researcher in the Institute of Molecular Genetics of the Italian National Research Council (CNR), lab of Genome Stability and DNA damage response, with more than 100 publications. Formerly, Lecturer in Physiopathology of the Cell Cycle, in the Medical Faculty of Pavia University, Dr. Prosperi is currently a teacher in the PhD program in “Genetics, Molecular and Cellular Biology” (Pavia University).
B. Sarkadi National Medical Center Budapest Hungary Biography
Biography of B. Sarkadi
Balázs Sarkadi, MD, Ph.D., spent several years as a post-doc and then as a visiting scientist at major universities in the United States and Canada. He is research professor at Semmelweis University, member of the Hungarian Academy of Sciences, past president of FEBS, member of several international research societies including the Academia Europeae. His research has been focusing on membrane proteins, including the investigation of ABC membrane transporters, which play a major role in the multidrug resistance of cancer, in general pharmacology, and in stem cell function. He has published more than 250 papers in international scientific journals, with a citation number over 13,000.
S. Scala National Cancer Institute "G. Pascale" Naples Italy
M.S. Sheikh SUNY Upstate Medical University Syracuse, NY USA
K.S. Srivenugopal Texas Tech University Health Sciences Center Amarillo, Texas USA Biography
Biography of K.S. Srivenugopal
Dr. Kalkunte Srivenugopal obtained his Ph.D. in Biochemistry From the Indian Institute of Science. He has been in the United States since 1981 and is currently a tenured Professor of Biomedical Sciences at the Texas Tech University School of Pharmacy in Amarillo, Texas, USA. Dr. Srivenugopal’s research interests include brain tumor chemotherapy, DNA repair, drug discovery, p53 biology and redox signaling. He has received funding from the National Institutes of Health, Cancer Prevention Research Institute of Texas and many private foundations. He has published more than 85 peer-reviewed articles.
G.S.W. Tsao University of Hong Kong Pok Fu Lam Hong Kong
W. Wang Hunan University of Chinese Medicine Hunan China
L. Zhang University of Pittsburgh Pittsburgh, PA USA
Executive Guest Editor(s)
H. Konig Indiana University Melvin and Bren Simon Cancer Center Indianapolis, IN USA Biography
Biography of H. Konig
Dr. Heiko Konig received his MD and doctoral degrees from the medical schools at the Ludwig Maximilians University Munich and the Philipps University Marburg/ Germany, respectively. Following his clinical and research training in internal medicine and hematology/ oncology at the University of Heidelberg/Mannheim, he completed a postdoctoral research fellowship in leukemia stem cell research at City of Hope/CA. He then received further residency training in internal medicine at St. Louis University as well as fellowship training in medical oncology at the Johns Hopkins Hospital in Baltimore/MD. He is currently an Assistant Professor at the Indiana University Melvin & Bren Simon Cancer Center in Indianapolis where is effort is dedicated to the care of patients with acute myeloid leukemia (AML) and other hematological malignancies, and laboratory based research with a focus on the role of hypoxia in the development of AML drug resistance and minimal residual disease. Dr. Konig is also serving as the co-chair of the Big Ten Cancer Research Consortium (BTCRC) Myeloid Malignancies Clinical Trial Working Group and the Hoosier Cancer Research Network (HCRN) Lymphoma/Leukemia Clinical Trial Working Group.
G. Liu Beijing Normal University Beijing China
V. Tuchin Saratov State University Saratov Russia Biography
Biography of V. Tuchin
Valery V. Tuchin is a professor and chair of Optics and Biophotonics at Saratov State
University (National Research University of Russia). He is also the head of Laboratory of Laser
Diagnostics of Technical and Living Systems, Institute of Precision Mechanics and Control,
RAS, and the supervisor of Interdisciplinary Laboratory of Biophotonics at Tomsk State
University (National Research University of Russia) and Laboratory of FemtoMedicine of ITMO
University (National Research University of Russia). His research interests include tissue optics,
laser medicine, tissue optical clearing, and nanobiophotonics. He is a member of SPIE, OSA, and
IEEE, Guest Professor of HUST (Wuhan) and Tianjin Universities of China, and Adjunct
Professor of the Limerick University (Ireland) and National University of Ireland (Galway).
Prof. Tuchin is a fellow of SPIE and OSA, he was awarded the Honored Science Worker of the
Russia, Honored Professor of Saratov State University, SPIE Educator Award, FiDiPro
(Finland), Chime Bell Prize of Hubei Province (China), Joseph W. Goodman Book Writing
Award (OSA/SPIE), and OSA Michael S. Feld Biophotonics Award for pioneering research in
biophotonics. He has published more than 700 papers (Web of Science), 27 monographs and text-books, and
58 book chapters. Dr. Tuchin is also a holder of more than 50 patents. His works were cited
24431 times to August, 2019 (Google Scholar).
Ruiwen Zhang Center for Drug Discovery University of Houston 3455 Cullen Blvd. Houston, TX 77204 USA